Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
LUCD
LUCD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LUCD News
Supreme Court Strikes Down Trump's Tariffs, New 15% Levy Announced
Feb 23 2026
CNBC
PAVmed Secures $30 Million in Series D Preferred Stock Offering
Feb 04 2026
PRnewswire
PAVmed Subsidiary Secures VA Contract for EsoGuard Test, Expanding Access to Over 9 Million Veterans
Jan 22 2026
Benzinga
Lucid Diagnostics Secures VA Contract for EsoGuard, Boosting PAVmed Stock by 291%
Jan 21 2026
Benzinga
PAVmed Subsidiary Wins VA Contract for Esophageal Precancer Testing, Shares Surge 250%
Jan 21 2026
stocktwits
Lucid Diagnostics (LUCD) Secures VA Contract for EsoGuard Esophageal DNA Test at Medicare Pricing
Jan 21 2026
seekingalpha
Lucid Diagnostics Secures VA Contract for EsoGuard Test, Expanding Access to 9 Million Veterans
Jan 21 2026
Newsfilter
PAVmed Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing
Dec 30 2025
PRnewswire
PAVmed Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing
Dec 30 2025
Newsfilter
Lucid Diagnostics Reports 95% Success Rate in 11,991 EsoGuard Tests for Esophageal Cancer Screening
Dec 09 2025
Newsfilter
Lucid Diagnostics submits registration for $175 million mixed securities shelf offering
Dec 08 2025
SeekingAlpha
Wednesday's Underperforming Sectors: Diagnostics, Medical Instruments, and Supplies
Nov 26 2025
NASDAQ.COM
Lucid Diagnostics Recognized as a Top-Ranking Honoree in GenomeWeb's 2025 Best Places to Work
Nov 20 2025
Newsfilter
Lucid Diagnostics to Join Canaccord Genuity's MedTech, Diagnostics, and Digital Health & Services Forum
Nov 13 2025
Newsfilter
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Nov 12 2025
PRnewswire
Sensus Healthcare, Inc. (SRTS) Announces Q3 Loss While Exceeding Revenue Projections
Nov 07 2025
NASDAQ.COM
Show More News
